NEW YORK (GenomeWeb News) – Life sciences marketing company Genycell will distribute and sell ImaGenes' clone collection in Spain and Portugal, ImaGenes said today.

Granada, Spain-based Genycell will market ImaGenes clone collections, which includes open reading frame clones from Invitrogen and Genecopoeia, as well as the ORFeome Collection, which is a National Institutes of Health-led initiative to provide most human ORFs as a source of sequence-validated cDNA, ImaGenes said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.